National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences, Aichi, Japan.
Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Aichi, Japan.
Br J Pharmacol. 2023 Jan;180(1):94-110. doi: 10.1111/bph.15942. Epub 2022 Oct 3.
Capillary arterialization, characterized by the coverage of pre-existing or nascent capillary vessels with vascular smooth muscle cells (VSMCs), is critical for the development of collateral arterioles to improve post-ischaemic blood flow. We previously demonstrated that the inhibition of transient receptor potential 6 subfamily C, member 6 (TRPC6) channels facilitate contractile differentiation of VSMCs under ischaemic stress. We here investigated whether TRPC6 inhibition promotes post-ischaemic blood flow recovery through capillary arterialization in vivo.
Mice were subjected to hindlimb ischaemia by ligating left femoral artery. The recovery rate of peripheral blood flow was calculated by the ratio of ischaemic left leg to non-ischaemic right one. The number and diameter of blood vessels were analysed by immunohistochemistry. Expression and phosphorylation levels of TRPC6 proteins were determined by western blotting and immunohistochemistry.
Although the post-ischaemic blood flow recovery is reportedly dependent on endothelium-dependent relaxing factors, systemic TRPC6 deletion significantly promoted blood flow recovery under the condition that nitric oxide or prostacyclin production were inhibited, accompanying capillary arterialization. Cilostazol, a clinically approved drug for peripheral arterial disease, facilitates blood flow recovery by inactivating TRPC6 via phosphorylation at Thr69 in VSMCs. Furthermore, inhibition of TRPC6 channel activity by pyrazole-2 (Pyr2; BTP2; YM-58483) promoted post-ischaemic blood flow recovery in Apolipoprotein E-knockout mice.
Suppression of TRPC6 channel activity in VSMCs could be a new strategy for the improvement of post-ischaemic peripheral blood circulation.
毛细血管动脉化的特征是血管平滑肌细胞(VSMCs)覆盖预先存在或新生的毛细血管,这对于形成侧支小动脉以改善缺血后血流至关重要。我们之前的研究表明,瞬时受体电位 6 亚家族 C,成员 6(TRPC6)通道的抑制促进了 VSMCs 在缺血应激下的收缩分化。我们在此研究了在体内,TRPC6 抑制是否通过毛细血管动脉化促进缺血后血流恢复。
通过结扎左股动脉使小鼠发生后肢缺血。通过缺血左肢与非缺血右肢的比值计算外周血流恢复率。通过免疫组织化学分析血管数量和直径。通过 Western blot 和免疫组织化学测定 TRPC6 蛋白的表达和磷酸化水平。
尽管据报道,缺血后血流恢复依赖于内皮依赖性舒张因子,但在抑制一氧化氮或前列环素生成的情况下,全身 TRPC6 缺失可显著促进血流恢复,同时伴有毛细血管动脉化。西洛他唑是一种用于治疗外周动脉疾病的临床批准药物,通过在 VSMCs 中磷酸化 Thr69 使 TRPC6 失活,促进血流恢复。此外,通过吡唑-2(Pyr2;BTP2;YM-58483)抑制 TRPC6 通道活性可促进载脂蛋白 E 敲除小鼠缺血后的血流恢复。
抑制 VSMCs 中的 TRPC6 通道活性可能是改善缺血后外周血液循环的新策略。